Vimarsana
Biggest News Aggregation in the World

Page 16 - Kumar Paul News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kumar Paul. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kumar Paul Today - Breaking & Trending Today

Gilead to ship 450,000 remdesivir vials to India as virus cases surge - Vimarsana News

Gilead to ship 450,000 remdesivir vials to India as virus cases surge

Gilead to ship 450,000 remdesivir vials to India as virus cases surge Gilead Sciences Inc said on Monday it will give India at least 450,000 vials of its antiviral drug remdesivir and help boost production, as the world’s second-most populous country reels from surging coronavirus cases. Remdesivir is approved in India for restricted emergency use to treat severe COVID-19 cases, but hospitals are facing supply shortages due to indiscriminate use and the drug is being sold at over 10 times its listed price in the black market, reports Reuters. The shortage has raised concerns about hoarding ...

US drugmakers step up supplies as India battles COVID-19 surge - Vimarsana News

US drugmakers step up supplies as India battles COVID-19 surge

US drugmakers step up supplies as India battles COVID-19 surge Toggle share menu Advertisement US drugmakers step up supplies as India battles COVID-19 surge FILE PHOTO: An ampule of Gilead Sciences COVID-19 antiviral remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany on Apr 18, 2020. (Ulrich Perrey/Pool via Reuters) 27 Apr 2021 11:30PM (Updated: 27 Apr 2021 11:33PM) Share this content Bookmark CALIFORNIA: US drugmaker Merck & Co joined Gilead Sciences on Tuesday (Apr 27) in lending support to Ind...

Dilip Kumar Paul - Latest news and updates - Vimarsana News

Dilip Kumar Paul - Latest news and updates

WHO IS DILIP KUMAR PAUL? Dilip Kumar Paul   The 64-year-old leader hailed from a traditional business family in Silchar and completed his B.Com from Gauhati University in 1977. In 1983, Paul joined the BJP as a primary member in the Cachar district. From 1997 to 2002, he was the BJP Ward President of Silchar. Later in 2012, the Assamese leader became the President of the BJP Town Mandal Committee.   Paul was elected as the Member of Legislative Assembly for the first time in 2014 and in 2016 for the second time, defeating Congress leaders both times. He...

WHO warns of global surge in COVID cases, deaths as world approaches 'highest rate of infection' - Vimarsana News

WHO warns of global surge in COVID cases, deaths as world approaches 'highest rate of infection'

ABC News Turn on desktop notifications for breaking stories about interest? OffOn The WHO said the global infection rate was approaching the highest so far. • 7 min read COVID-19 emergency plagues Brazil, hospitals overflow with patients Field hospitals in Brazil are overflowing and thousands of hospitals are short or out of sedatives. Critics blame the surge on Brazil’s President Jair Bolsonaro for shunning masks and social distancinManish Swarup/AP LONDON -- The pandemic is reaching deadly new heights across the world, the WHO warned this week, even as the focus in some countries, inc...

Source: go.com
India wants Pfizer, Moderna, Johnson & Johnson to seek licence for COVID-19 vaccines soon - govt official - Vimarsana News

India wants Pfizer, Moderna, Johnson & Johnson to seek licence for COVID-19 vaccines soon - govt official

April 13, 20211:05 PM UTC IndiaIndia wants Pfizer, Moderna, Johnson & Johnson to seek licence for COVID-19 vaccines soon - govt official Reuters 1 minute read Vials of the Pfizer-BioNTech vaccine are pictured in a vaccination centre in Geneva, Switzerland, February 3, 2021. REUTERS/Denis Balibouse/File Photo India wants Pfizer, Moderna and Johnson & Johnson to seek licence for their COVID-19 vaccines as soon as possible, a senior government official said on Tuesday, shortly after the government announced it would fast-track emergency approvals. “We hope and we invite the vaccine mak...